Basetrophy Group Holdings Limited (8460.HK) Stock Overview
Explore Basetrophy Group Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.
Basetrophy Group Holdings Limited (8460.HK)
Key Financials
Key Financials
Market Cap
87.6M
P/E Ratio
-8.72
EPS (TTM)
$-0.03
ROE
-0.22%
8460.HK Stock Analysis & Investment Overview (HKSE)
Our AI-powered analysis of Basetrophy Group Holdings Limited (HKSE: 8460.HK) gives investors deep insight into how the stock performs on the HKSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Basetrophy Group Holdings Limited's HKSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 8460.HK on the HKSE shows an RSI of 18.12, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $2.07 for the HKSE listing.
Key metrics behind Basetrophy Group Holdings Limited's HKSE-traded stock include a P/E ratio of -8.72 and a market capitalization of 87.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of 8460.HK on the HKSE.